India GLP-1 Receptor Agonist Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By Route of Administration (Parenteral, Oral), By Product, By Distribution Channel, And Segment Forecasts

Market Segmentation

India GLP-1 Receptor Agonist Product Outlook (Revenue, USD Million, 2018 - 2030)
- Ozempic (semaglutide)
- Trulicity
- Mounjaro (tirzepatide)
- Wegovy (semaglutide)
- Rybelsus (oral semaglutide)
- Saxenda
- Victoza (liraglutide)
- Zepbound
- Other Products (SOLIQUA (lixisenatide), Bydureon)
India GLP-1 Receptor Agonist Application Outlook (Revenue, USD Million, 2018 - 2030)
- Type 2 Diabetes Mellitus
- Obesity
India GLP-1 Receptor Agonist Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Parenteral
- Oral
India GLP-1 Receptor Agonist Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
India GLP-1 Receptor Agonist Country Outlook (Revenue, USD Million, 2018 - 2030)
- India
  - India GLP-1 Receptor Agonist Market, by Product
    - Ozempic (semaglutide)
    - Trulicity
    - Mounjaro (tirzepatide)
    - Wegovy (semaglutide)
    - Rybelsus (oral semaglutide)
    - Saxenda
    - Victoza (liraglutide)
    - Zepbound
    - Other Products (SOLIQUA (lixisenatide), Bydureon)
  - India GLP-1 Receptor Agonist Market, by Application
    - Type 2 diabetes mellitus
    - Obesity
  - India GLP-1 Receptor Agonist Market, by Route of Administration
    - Parenteral
    - Oral
  - India GLP-1 Receptor Agonist Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Online Pharmacies

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments